PENZBERG, Germany–BOTOX® is an important medicine that over the last 15 years of clinical use has helped millions of patients with serious medical conditions worldwide. Pharmaceutical manufacturers using Clostridium botulinum toxin (BOTOX®) in drugs are required by the Food and Drug Administration (FDA) in the United States and by other worldwide health regulatory agencies to […]

SOUTH EASTON, Mass., Aug. 6 — Pressure BioSciences, Inc. (Nasdaq: PBIO – News; “PBI” or “the Company”) today announced the market release of its pressure cycling technology (“PCT”)-enhanced trypsin digestion application for proteomics, a major new addition to its PCT family of products. Named “Proteolysis (Trypsin)-PrEP”, this new PCT-enhanced processing (“PrEP”) application was unveiled at […]

Addition of Structure-to-Name Conversion Toolkit Will Enhance Chemical Compound Searching and Improve Productivity for Researchers Using Symyx(R) Applications SANTA CLARA, CA and SANTA FE, NM–Aug 6, 2008 — In an extension of its strategic partnership, Symyx Technologies, Inc. (SMMX – News) plans to integrate OpenEye’s Lexichem(TM) structure-name converter software with Symyx Draw and other key […]

Company expands beyond core business of discovery and safety services to BOSTON and CLEVELAND, Aug. 6 — ChanTest, the world-leading provider of validated ion channel-expressing cell lines and services for drug-discovery and development applications, will make a selection of its fully validated cell lines available to researchers through a new Web site: https://www.chantestchannels.com. ChanTest Founder […]

– Goal Is Development of a Fully Integrated Nanochannel Chip and Reader for Single-Molecule Mapping, Enabling Direct Visualization and Analysis of Long Strands of DNA in Context and at Very High Resolution – PHILADELPHIA, Aug. 6 — BioNanomatrix, Inc., a developer of breakthrough nanoscale whole genome imaging platforms for genetic diagnostics, personalized medicine and biomedical […]

MUKILTEO, Wash., Aug. 6, 2008 (PRIME NEWSWIRE) — CombiMatrix Corporation (NasdaqGM:CBMX – News) announced today that renowned cancer expert, Colin Collins, Ph.D., has joined the Scientific Advisory Board (SAB) of its subsidiary reference laboratory Combimatrix Molecular Diagnostics (CMDX). Dr. Collins is an Associate Professor of Urology at the Cancer Research Institute and Department of Laboratory […]

Study of 19,000 DNA Samples Aimed at Genetic Causes of 11 Widespread Diseases SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE:A – News) today announced that the Wellcome Trust Case Control Consortium (WTCCC) will standardize the world’s largest human genomic copy number variation (CNV) study on Agilent microarrays. The study is designed to determine genetic causes of […]

PerkinElmer is pleased to announce the newest Addition to PerkinElmer’s Molecular-based Product Portfolio and aCGH Product Family. The Constitutional Chip 4.0 for aCGH studies demonstrates continued synergies, resulting from the spectral genomics, Inc. asset acquisition Features and benefits of the Constitutional Chip 4.0 include; more well-characterized clinically significant chromosomal regions — 4.0 is composed of […]

SAN DIEGO & MONTREAL–Sequenom, Inc. (NASDAQ: SQNM – News), a leading provider of genetic analysis solutions, and Génome Québec today announced that the McGill University and Génome Québec Innovation Centre has become the first Center of Excellence certified by Sequenom for genotyping technology. The Center of Excellence certification is a collaborative partner relationship aimed at […]

Tripos Benchware(R) Discovery 360 Product in Joint Venture to Support Wyeth Discovery Research ST. LOUIS, Aug 05, 2008 — Tripos International, a leading provider of drug discovery informatics products and services, today announced the implementation of the Benchware(R) Discovery 360 system (v. 4.0) by Wyeth Discovery Research as part of a joint project with global […]